ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #105Top JournalReview JournalHybrid

Nature Reviews Endocrinology

Acronym:nrendo
•
Abbreviation (ISO):NAT REV ENDOCRINOL
•
Identifier (ISSN):1759-5029(Print)/1759-5037(Online)
•
Publisher:Springer Nature
Clarivate IF (2026)
39.1↓ -0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Nature Reviews Endocrinology

WoS Q1
1430456120.3201824.6201928.8202043.3202147.6202240.5202331.0202440.0202539.12026
Annual Impact Factor Metric
Current (2026):39.1
Scopus SJR & RankScopus Q1
9.087
#105

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
240

240 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
48articles/year
1.46% Gold OA•18.18% Original Research

Aims & Scope

Nature Reviews Endocrinology aims to be the premier source of reviews and commentaries for the scientific communities we serve. We strive to publish articles that are authoritative, accessible and enhanced with clearly understandable figures, tables and other display items. We want to provide an unparalleled service to authors, referees and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements and Perspectives relevant to researchers and clinicians working in the fields of endocrinology and metabolism, with our broad scope ensuring that the work we publish reaches the widest possible audience. This page gives more detail about the aims and scope of the journal.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineEndocrinologyChemistryBiochemistryGeneticsPathologyBioinformaticsIntensive Care Medicine

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank1/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q1
Rank4/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF39.1
Articles / Year84
Total Citations97
2025
IF40
Articles / Year146
Total Citations1,606
2024
IF31
Articles / Year139
Total Citations3,551
2023
IF40.5
Articles / Year145
Total Citations5,694
2022
IF47.564
Articles / Year171
Total Citations10,962

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #105Scopus Q1SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
9.087

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
13.58

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,906 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations6,617
3-Year Documents448
Citable Documents216

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate48.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ1
Endocrinology, Diabetes and MetabolismQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Nature Reviews Endocrinology (acronym: nrendo, abbr: NAT REV ENDOCRINOL, ISSN: 1759-5029) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in England since 2009. The periodical holds a Journal Impact Factor (JIF) of 39.1, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 9.087 (Q1), an H-index of 240.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 48 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,906 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
Monthly
Founding Year
2009
Indexing & Databases
SCIEScopusPubMed
Editorial Address
NATURE PUBLISHING GROUP, 75 VARICK ST, 9TH FLR, NEW YORK, USA, NY, 10013-1917

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4ebffbed-2ba5-4500-9b96-027d334447a3
Database Updated: 2026-09-28